Bryophyllum pinnatum leaves ethanol extract inhibit maturation and promote apoptosis of systemic lupus erythematosus BALB/c mice B cells

  • Kusworini Handono Department of Clinical Pathology, Faculty of Medicine, Universitas Brawijaya, Malang
  • Tri W.I. Dantara Biomedical Sciences Master Program, Faculty of Medicine, Universitas Brawijaya, Malang
  • Elvira S. Dewi Nursing Program, Faculty of Medicine, Universitas Brawijaya, Malang
  • Mirza Z. Pratama Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang
  • Nurdiana Nurdiana Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang
DOI: https://doi.org/10.13181/mji.v26i4.1899
Keywords: B cells, Bryophyllum pinnatum, pristane, SLE
Abstract viewed: 1387 times
PDF downloaded: 932 times
HTML downloaded: 135 times
EPUB downloaded: 138 times

Abstract

Background: B cells play a key role in systemic lupus erythematosus (SLE). Targeting B cells as SLE therapy is a plausible approach. This study investigated the potential effects of Bryophyllum pinnatum leaves with ethanol extract in decreasing percentages of maturation, increasing percentages of apoptosis, and decreasing NF-κB p65 expressions of SLE BALB/c mice B cells.

Methods: Culturing B cells from pristane induced SLE BALB/c mice's spleen will resulted in this in vitro study. B cells were activated by BAFF, LPS, IL-4, and anti-CD40 yielding CD19+ >80%. B cells were cultured by adding those stimulants with and without B. pinnatum leaves (0, 0.02, 0.1, or 0.5 µg/ml) for 72 hours at 37°C. Flow cytometry was performed to determine The Percentages of maturation (CD19+CD38+) and apoptosis (Annexin V+PI+) of B cells. Further analysis to determine the expressions of transcription factor of maturation and apoptosis of B cells, NF-κB p65, were performed using immunocytochemistry. Data were analyzed using SPSS version 22.

Results: Flow cytometry assay showed significant decrease in percentages of maturation of B cells in all doses and significant increase in percentage of apoptosis of B cells in dose 0.5 µg/ml. Immunocytochemistry results showed significant decrease expressions of NF-κB p65 in all doses. Percentages of maturation, apoptosis, and expressions of NF-κB p65 of B cells were significantly correlated.

Conclusion: This in vitro study revealed that B. pinnatum leaves with ethanol extract decreased the percentages of maturation, increased the percentage of apoptosis, and decreased NF-κB p65 expressions of SLE BALB/c mice B cells significantly.

References

  1. Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2010; 43(1): 84–97. https://doi.org/10.3109/08916930903374600

  2. Pateinakis P, Pyrpasopoulou A. Targeting the B-cell pathway in lupus nephritis: current evidence and future perspectives. Sci World J. 2013;2013:745239. https://doi.org/10.1155/2013/745239

  3. Leiss H, Niederreiter B, Bandur T, Schwarzecker B, Blüml S, Steiner G, et al. Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation. Lupus. 2013;22(8):778–92. https://doi.org/10.1177/0961203313492869

  4. Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009;30(9):455–64. https://doi.org/10.1016/j.it.2009.06.003

  5. Zhuang H, Szeto C, Han S, Yang L, Reeves WH. Animal models of interferon signature positive lupus. Front Immunol. 2015;6(291):1–6. https://doi.org/10.3389/fimmu.2015.00291

  6. Postal M, Costallat LT, Appenzeller S. Biological therapy in systemic lupus erythematosus. Int J Rheumatol. 2012;2012:578641. https://doi.org/10.1155/2012/578641

  7. Anolik JH. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus. 2013;22(4):342–9. https://doi.org/10.1177/0961203312471576

  8. Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzová D, et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011;63(12):3918–30. https://doi.org/10.1002/art.30613

  9. Hahn BH. Belimumab for systemic lupus erythematosus. N Engl J Med. 2013;368(16):1528–35. https://doi.org/10.1056/NEJMct1207259

  10. Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol. 2014;10(6):365–73. https://doi.org/10.1038/nrrheum.2014.33

  11. Fürer K, Simões-Wüst AP, Von Mandach U, Hamburger M, Potterat O. Bryophyllum pinnatum and related species used in anthroposophic medicine: constituents, pharmacological activities, and clinical efficacy. Planta Med. 2016;82(11–12):930–41. https://doi.org/10.1055/s-0042-106727

  12. Oufir M, Seiler C, Gerodetti M, Gerber J, Fürer K, Mennet-von EM, et al. Quantification of bufadienolides in Bryophyllum pinnatum leaves and manufactured products by UHPLC-ESIMS/MS. Planta Med. 2015;81(12–13):1190–7. https://doi.org/10.1055/s-0035-1546126

  13. Anjoo K, Kumar SA. Microscopical and preliminary phytochemical studies on aerial part (leaves and stem) of Bryophyllum Pinnotum Kurz. Phcog J. 2010;2(9):254–9. https://doi.org/10.1016/S0975-3575(10)80113-0

  14. Nwali BU, Okaka ANC, Ibiam UA, Aja PM. Phytochemical composition of Bryophyllum pinnatum leaves. Int J Adv Biol Res. 2012;2(4):614–6.

  15. Zhang X-A, Zhang S, Yin Q, Zhang J. Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B pathway. Pharmacogn Mag. 2015;11(42):404–9. https://doi.org/10.4103/0973-1296.153096

  16. Simões-Wüst AP, Jeschke E, Mennet M, Schnelle M, Matthes H, von Mandach U. Prescribing pattern of Bryophyllum preparations among a network of anthroposophic physicians. Forsch Komplementmed. 2012;19(6):293–301. https://doi.org/10.1159/000345841

  17. Gründemann C, Diegel C, Sauer B, Garcia-Käufer M, Huber R. Immunomodulatory effects of preparations from Anthroposophical Medicine parenteral use. BMC Complement Altern Med. 2015;15:219. https://doi.org/10.1186/s12906-015-0757-6

  18. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15(1):49–63. https://doi.org/10.1038/nrm3722

  19. Kalim H, Handono K, Khalasa T, Pratama MZ, Dantara TWI, Wulandari AP, et al. Immune modulation effects of curcumin in pristane induced lupus mice. Indian J Rheumatol. 2017;12(2):86–93. https://doi.org/10.4103/injr.injr_95_16

  20. Pawar RD, Goilav B, Xia Y, Zhuang H, Herlitz L, Reeves WH. Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin. Clin Immunol. 2014;154(1):49–65. https://doi.org/10.1016/j.clim.2014.06.007

  21. Yaniv G, Twig G, Shor DBA, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14(1):75–9. https://doi.org/10.1016/j.autrev.2014.10.003

Published
2018-02-14
How to Cite
1.
Handono K, Dantara TW, Dewi ES, Pratama MZ, Nurdiana N. <em>Bryophyllum pinnatum</em&gt; leaves ethanol extract inhibit maturation and promote apoptosis of systemic lupus erythematosus BALB/c mice B cells. Med J Indones [Internet]. 2018Feb.14 [cited 2024Apr.19];26(4):253-60. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/1899
Issue
Vol. 26 No. 4 (2017): December
Section
Basic Medical Research

Copyright (c) 2018 Kusworini Handono, Tri W.I. Dantara, Elvira S. Dewi, Mirza Z. Pratama, Nurdiana Nurdiana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.